These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11724103)

  • 1. The debate regarding continuous use of oral contraceptives.
    Clarke AK; Miller SJ
    Ann Pharmacother; 2001 Nov; 35(11):1480-4. PubMed ID: 11724103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-cycle treatment with oral contraceptives.
    Wiegratz I; Kuhl H
    Drugs; 2004; 64(21):2447-62. PubMed ID: 15482002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives.
    Shearman RP
    Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metrorrhagia caused by estrogen-progestin combinations].
    Erny R; Erny N
    Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triphasics: have they fulfilled their promise?
    Weisberg E
    Curr Ther (Seaforth); 1992 Jan; 33(1):11-6. PubMed ID: 12286973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic effects of oral contraceptives.
    Grimes DA
    Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of triphasic oral contraceptives in a continuous use regimen.
    Shulman LP
    Contraception; 2005 Aug; 72(2):105-10. PubMed ID: 16022848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended- and continuous-cycle oral contraceptives.
    Shrader SP; Dickerson LM
    Pharmacotherapy; 2008 Aug; 28(8):1033-40. PubMed ID: 18657019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding.
    Sulak PJ; Carl J; Gopalakrishnan I; Coffee A; Kuehl TJ
    Contraception; 2004 Oct; 70(4):281-7. PubMed ID: 15451331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous use of oral contraceptives: an overview of effects and side-effects.
    Hee L; Kettner LO; Vejtorp M
    Acta Obstet Gynecol Scand; 2013 Feb; 92(2):125-36. PubMed ID: 23083413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communicating with patients about extended-cycle and continuous use of oral contraceptives.
    Nelson AL
    J Womens Health (Larchmt); 2007 May; 16(4):463-70. PubMed ID: 17521249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of oral contraceptive clinical development in Japan.
    Kuwabara Y
    Int J Fertil; 1989; 34 Suppl():18-20. PubMed ID: 2576251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.